A 7-Week, Randomized, Double-Blind Trial of Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Determine the efficacy and tolerability of olanzapine/fluoxetine combination (OFC) for treatment of acute bipolar I depression compared with lamotrigine. METHOD: The 7-week, acute phase of a randomized, double-blind study compared OFC (6/25, 6/50, 12/25, or 12/50 mg/day; N = 205) with lamotrigine ([LMG] titrated to 200 mg/day; N = 205) in patients with DSM-IV-diagnosed bipolar I disorder, depressed. The study was conducted from November 2003 to August 2004. RESULTS: Completion rates were similar between treatments (OFC, 66.8% vs. LMG, 65.4%; p = .835). OFC-treated patients had significantly greater improvement than lamotrigine-treated patients in change from baseline across the 7-week treatment period on the Clinical Global Impressions-Severity of Illness scale (primary outcome) (p = .002, effect size = 0.26), Montgomery-Asberg Depression Rating Scale (MADRS) (p = .002, effect size = 0.24), and Young Mania Rating Scale total scores (p = .001, effect size = 0.24). Response rates did not significantly differ between groups when defined as > or = 50% reduction in MADRS score (OFC, 68.8% vs. LMG, 59.7%; p = .073). Time to response was significantly shorter for OFC-treated patients (median days [95% CI] = OFC, 17 [14 to 22] vs. LMG, 23 [21 to 34]; p = .010). There was a significant difference in incidence of "suicidal and self-injurious behavior" adverse events (OFC, 0.5% vs. LMG, 3.4%; p = .037). Somnolence, increased appetite, dry mouth, sedation, weight gain, and tremor occurred more frequently (p < .05) in OFC-treated patients than lamotrigine-treated patients. Weight, total cholesterol, and triglyceride levels were significantly elevated in OFC-treated patients compared with lamotrigine-treated patients (all p < or = .001). CONCLUSIONS: Patients with acute bipolar I depression had statistically significantly greater improvement in depressive and manic symptoms, more treatment-emergent adverse events, greater weight gain, and some elevated metabolic factors with OFC than lamotrigine. Treatment differences were of modest size.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Olanzapine‐fluoxetine combination (level 2)264, 265 is effective and is also recommended as a second‐line option.”
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 239
Ansari, A., & Osser, D. N. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673220903523524 · Cited by 20
Bipolar depression: a review of randomised clinical trials
Goodnick, P. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.1.13 · Cited by 17
Overview of Antidepressant Treatment of Bipolar Depression
Vázquez, G. H., Tondo, L., Undurraga, J. P., & Baldessarini, R. J. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130119 · Cited by 15
An update on the treatment of bipolar depression
Azorin, J., & Kaladjian, A. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802653172 · Cited by 15
Pharmacological treatment of bipolar depression
Vázquez, G. H., Tondo, L., Undurraga, J. P., Zaratiegui, R. M., Selle, V., & Baldessarini, R. J. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.113.011460 · Cited by 13
The role of quetiapine extended release in the treatment of bipolar depression
Cristancho, M., & Thase, M. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0067-9 · Cited by 14
Systematic Review of Recent Guidelines for Pharmacological Treatments of Bipolar Disorders in Adults
Hammett, S., & Youssef, N. A. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900409 · Cited by 14
A Critical Appraisal of Treatments for Bipolar Disorder
Nierenberg, A. A. (2010) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.9064su1c.04 · Cited by 13
Pharmaceutical treatment of acute bipolar depression
Fountoulakis, K. Ν. (2010) · F1000 Medicine Reports · doi:10.3410/m2-47 · Cited by 12
Treating bipolar depression – antidepressants and alternatives: a critical review of the literature
Tundo, A., Cavalieri, P., Navari, S., & Marchetti, F. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00542.x · Cited by 12
Treatment of bipolar depression
Musetti, L., Grande, C. D., Marazziti, D., & Dell’Osso, L. (2013) · CNS Spectrums · doi:10.1017/s1092852912001009 · Cited by 10
Oxford Handbook of Clinical Specialties
Baldwin, A., Hjelde, N., Goumalatsou, C., & Myers, G. (2016) · doi:10.1093/med/9780198719021.001.0001 · Cited by 9
New Approaches in the Treatment of Bipolar Depression
Saunders, K., & Goodwin, G. M. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_209 · Cited by 11
Sharma, D., Higgins, O., Sawicki, A., Ramamurthy, P., Field, B., Hussein, P., Singh, K. A., & Ranjitkar, S. (2025) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13639 · Cited by 8
Fixed dose-combination products in psychiatry: Systematic review and meta-analysis
Farooq, S., & Singh, S. P. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114541016 · Cited by 7
The Treatment of Bipolar Depression: Current Status and Future Perspectives
Jelen, L. A., & Young, A. H. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00200-x · Cited by 7
Arnone, D., Östlundh, L., Mosa, M., MacDonald, B., Oldershaw, J., Qassem, T., & Young, A. H. (2025) · Pharmaceuticals · doi:10.3390/ph18101590 · Cited by 7
Oxford Handbook of Clinical Specialties
(2020) · doi:10.1093/med/9780192888501.001.0001 · Cited by 6
Management of Bipolar Depression
Chang, J. S., & Ha, K. (2011) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.85390 · Cited by 8
Drug safety evaluation of olanzapine/fluoxetine combination
Cristancho, M. A., & Thase, M. E. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.933804 · Cited by 7
Utilización de olanzapina en el tratamiento de la esquizofrenia y el trastorno bipolar
Barbosa, L., & Bernardo, M. (2015) · Psiquiatría Biológica · doi:10.1016/j.psiq.2015.10.008 · Cited by 7
Spanemberg, L., Massuda, R., Lovato, L. M., Paim, L. L., Vares, E. A., da Rocha, N. S., & Ceresér, K. M. M. (2011) · Psychiatric Quarterly · doi:10.1007/s11126-011-9191-1 · Cited by 7
Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression
Dubovsky, S. L. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.761206 · Cited by 6
Gao, K., Kemp, D. E., Wu, R., & Calabrese, J. R. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch105 · Cited by 9
Shafiee, A., Moltazemi, H., Amini, M. J., Gargari, O. K., Safari, F., Abhari, F. S., Jafarabady, K., & Bakhtiyari, M. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103839 · Cited by 5
Spotlight on Olanzapine/Fluoxetine in Acute Bipolar Depression†
Deeks, E. D., & Keating, G. M. (2008) · CNS Drugs · doi:10.2165/00023210-200822090-00006 · Cited by 5
Unmet Needs in Psychiatry: Bipolar Depression
Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_4 · Cited by 8
Chapter 49. Treatment of Bipolar Disorder
Strakowski, S. M., & Keck, P. E. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as49 · Cited by 5
Self-citationBaldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_3 · Cited by 9
Nierenberg, A. A. (2007) · Evidence-Based Mental Health · doi:10.1136/ebmh.10.1.12 · Cited by 4
Fornaro, M., Lorenzo, C. D., Oliva, V., Prisco, M. D., & Vieta, E. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122160 · Cited by 4
Pharmacological treatment of bipolar depression
Young, A. H., & Nemeroff, C. B. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.004 · Cited by 3
Antipsicóticos para la depresión bipolar: la paradoja
Pacchiarotti, I. (2015) · Psiquiatría Biológica · doi:10.1016/s1134-5934(15)30007-5 · Cited by 3
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_16 · Cited by 3
Evidence Based Combination Therapy for Bipolar Disorder
Magiria, S., Siamouli, M., Gonda, X., Iacovides, A., & Fountoulakis, K. Ν. (2012) · Springer eBooks · doi:10.1007/978-94-007-5799-8_9 · Cited by 3
Metabolic Syndrome in Psychiatric Inpatients Treated for Depression
Goethe, J. W., Szarek, B. L., & Caley, C. F. (2008) · Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry · doi:10.1159/000189777 · Cited by 3
Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling
Datta, V., & Cleare, A. J. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.10 · Cited by 3
Effective treatments for suicidal youth: Pharmacological and psychosocial approaches
Brent, D. A. (2009) · doi:10.1093/med/9780198570059.003.0091 · Cited by 7
Pharmacotherapy for Bipolar Depression: A Review of the Evidence
Aarre, T. F., & Dahl, A. A. (2008) · Current Psychiatry Reviews · doi:10.2174/157340008785829913 · Cited by 3
The Role of Antidepressants in Bipolar Disorder
Yerevanian, B. I. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch15 · Cited by 2
Gao, K., & Calabrese, J. R. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as41 · Cited by 2
Pharmacological Profile and Clinical Utility of Lamotrigine in Mood Disorders
van der Loos, M. L. M., Calabrese, J. R., Nolen, W. A., & Muzina, D. J. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch4 · Cited by 2
Efficacy of Olanzapine for Treating Depressive Episodes in Bipolar Disorder
Kirino, E. (2014) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.5.11 · Cited by 2
Atypical Antipsychotics for Bipolar Disorder: Overblown or Blown Over?
Ng, F., Dodd, S., & Berk, M. (2007) · Deakin Research Online (Deakin University) · Cited by 2
Acute Bipolar Depression: A Review of the Use of Olanzapine/Fluoxetine
Bobo, W. V., EPSTEIN, R. A., & Shelton, R. C. (2010) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s1945 · Cited by 2
Recent advances in the biological treatment of mood disorders
McDonald, G., & Hallahan, B. P. (2009) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700000331 · Cited by 2
Pharmacological Treatment of Bipolar Disorder in the Elderly
Katz, T. C., Georgakas, J. E., Motyl, C. M., Quayle, W., & Forester, B. P. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0101-5 · Cited by 2
Vandevelde, A., Benbrika, S., Madigand, J., & Dollfus, S. (2021) · L Encéphale · doi:10.1016/j.encep.2020.10.004 · Cited by 2
Treating Bipolar Disorder in the Primary Care Setting: The Role of Aripiprazole
Manning, J. S., & McElroy, S. L. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08r00635 · Cited by 2
Self-citationPaun, R., Pavel, A. N., & Matei, V. P. (2020) · Psychiatry and Clinical Psychopharmacology · doi:10.5455/pcp.20200917051316 · Cited by 1
Pharmacoepidemiology of Bipolar Disorder: A Review
Dimellis, D., & Konstantinos, N. (2015) · Cited by 2
The Nature and Treatment of Bipolar Disorder and the Bipolar Spectrum
Otto, M. W., & Applebaum, A. J. (2014) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199328710.013.035 · Cited by 1
The use of atypical antipsychotic drugs in Bipolar II disorder
Vieta, E., & Cruz, N. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.013 · Cited by 1
Behandlung bipolarer Störungen
Grunze, H., Grunze, A., & Born, C. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1849-8_3 · Cited by 1
The use of atypical antipsychotic drugs in Bipolar II Disorder
Fresno, D., & Vieta, E. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.012 · Cited by 1
Vargas-Huicochea, I., Tamayo, J. M., & Ruíz, I. M. (2015) · Archivos de Neurociencias · doi:10.31157/an.v20i2.82 · Cited by 1
Ahearn, E. P., Chen, P., & Sajatovic, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00031-4 · Cited by 3
Pharmacological Treatment of Bipolar Depression
Young, A. H., & Nemeroff, C. B. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch23 · Cited by 1
Goumalatsou, C. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0001 · Cited by 1
Clutton, J. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0008 · Cited by 1
Clutton, J. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0007 · Cited by 1
Perlis, R. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50032-9 · Cited by 1
Myers, G. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0012 · Cited by 1
Combination Therapies and Switching of Agents in Depression and Bipolar Disorders
Folsche, T., Maier, H. B., Hillemacher, T., & Frieling, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_437 · Cited by 1
Management of Mental Health Disorders in Pregnancy
Grosse, D. G., & Aggarwal, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-36490-7_31 · Cited by 1
Pharmacological treatment of acute bipolar depression
Sachs, G. S., Sylvia, L. G., & Lund, H. G. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_9 · Cited by 1
Management of Bipolar Disorder in the Acute and Maintenance Settings
Baldassano, C. F. (2007) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390307305790 · Cited by 1
Hirschfeld, R. M. A. (2007) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.5.1.33 · Cited by 1
Pre-hospital emergency medicine
Collingwood, T. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0010 · Cited by 1
Easing the Burden of Bipolar Disorder: From Urgent Situations to Remission
(2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0507 · Cited by 1
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Ketter, T. A., & Wang, P. W. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.018
The acute treatment of bipolar depression: Historically relevant and recent controlled trials
Kronstein, P. D., & Zarate, C. A. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629389
Managing bipolar depression: a therapeutic challenge?
Feetam, C. (2011) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.218
Comprehensive Pharmacologic Management of Bipolar Depression
McGirr, A., & Bond, D. J. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0017-2
Recent Progress in the Pharmacotherapy of Bipolar Disorder
Mitchell, P. B., Loo, C. K. A., & Breakspear, M. J. (2009) · Future Neurology · doi:10.2217/fnl.09.18
Bipolar disorder pharmacotherapy
Denko, T., & Thase, M. E. (2007) · Future Neurology · doi:10.2217/14796708.2.4.441
Olanzapine in Treatment for Bipolar Disorder
Tohen, M. F., Campbell, G. M., & Lin, D. (2005) · Wiley eBooks · doi:10.1002/0470017953.ch6
Self-citationSomething Borrowed, Something Blue:Why is Bipolar Disorder an Orphan?
Nierenberg, A. A. (2010) · CNS Spectrums · doi:10.1017/s1092852900000250
Pharmacologic and somatic treatments for bipolar depression
Giner, L., Kelly, S. A., & Oquendo, M. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.007
Choosing Between Treatments for Bipolar Depression
Roy‐Byrne, P. (2006) · Journal watch · doi:10.1056/jp200608140000002
Aji, A. A. (2017) · Journal of psychiatry · doi:10.4172/2378-5756.1000415
Steventon, N. B. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780192888501.003.0005
Kloiber, S. M. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_46-1
Baldwin, A., & Myers, G. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0015
Combination Therapies and Switching of Agents in Depression and Bipolar Disorders
Folsche, T., Maier, H. B., Hillemacher, T., & Frieling, H. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_437-1 · Cited by 1
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg002
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.791
Arianayagam, S. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0006
Baldwin, A. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0013
Pharmacological Treatment of Acute Bipolar Depression
Sachs, G. S. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_9
Olanzapine in Treatment for Bipolar Disorder
Tohen, M. F., Campbell, G. M., & Gómez, J. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch6
Self-citation(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372997.as05
Baldwin, A., Hjelde, N., Goumalatsou, C., & Myers, G. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198719021.003.0006
Baldwin, A., Hjelde, N., Goumalatsou, C., & Myers, G. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198719021.003.0004
Buckley, S. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198827191.003.0003
Baldwin, A., Hjelde, N., Goumalatsou, C., & Myers, G. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198719021.003.0002
Baldwin, A., Hjelde, N., Goumalatsou, C., & Myers, G. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198719021.003.0008
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372300.as05
Baldwin, A., Hjelde, N., Goumalatsou, C., & Myers, G. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198719021.003.0003
Metadata
- Authors
- Brown, E. B., McElroy, S. L., Keck, P. E., Deldar, A., Adams, D. H., Tohen, M., & Williamson, D. J.
- Affiliations
- Eli Lilly (United States) (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-07-15
- Volume
- 67
- Issue
- 07
- Pages
- 1025-1033
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2011797837
- Cited by
- 244
- References
- 0
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 32 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 32 · 2015: 9 · 2014: 15 · 2013: 11 · 2012: 10
- FWCI
- 13.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- bipolar I depression, olanzapine-fluoxetine combination, lamotrigine, atypical antipsychotics, antidepressant efficacy, treatment response time, adverse events, weight gain, tolerability, mood stabilizers, Young Mania Rating Scale, Montgomery-Asberg Depression Rating Scale, clinical global impression
- MeSH terms
- Olanzapine, Lamotrigine, Adult, Anticonvulsants, Benzodiazepines, Bipolar Disorder, Depressive Disorder, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Female, Fluoxetine, Humans, Male, Psychiatric Status Rating Scales, Severity of Illness Index, Antipsychotic Agents, Triazines, Self-Injurious Behavior, Treatment Outcome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.